PYC pyc therapeutics limited

0.40%

$1.27

Hope so Heks but they have always had high hopes, expectations...

First 9 Last

Share
Profile

Follow
Akki

35,790 Posts.

555

23/05/16

11:35

Post #: 17840151
Share

Originally posted by Heskumdai ↑

Andrew and Akki, I hear you, as I am also a long suffering SH, but before you get too caught up in the notion they are only doing scientific studies like a uni group, take a moment to think through the commercial potential of what they are talking about - and have now given us time frames on. I mean it is mind bogglingly large. 90% of the worlds diseases are currently untreatable - but may not be for too much longer. What do you think this would be worth in commercial terms? More than $30m?

Anyway, in approx 6 mths they say they will provide proof of concept (animals models) that they can deliver biologics on an intracellular basis in therapeutic doses and with specificity. IF they can pull that off it's is a significant step that no body else in the world has achieved. To my mind this is very exciting as it seems to be what everyone is chasing, i.e. the holy grail....and we find this out in just 6 mths. I think there's value there, but clearly it's a punt as the science may not pan out, but if it does it should be of some value I would have thought.

No doubt in pharma land it's bound to be of interest. Whether its enough to convince them to open the cheque book, who knows. Maybe they say "come back when you have the full data pack" which could be 18 mths off - and closer to Andrew's thoughts re news just before another CR...?

Anyway, we can't expect them to rid the world of all known diseases overnight, so let's enjoy the fact they are (again) communicating and we have clear guidance. We can all make our own investment choices from here.

Expand

Hope so Heks but they have always had high hopes, expectations and earth shattering stories we will see I guess. Not sure about their 6 month timeline though they've never been very good there - maybe this time next year if we're lucky they might have something.

PYC Price at posting: 1.6¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 9 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.27		Change 0.005(0.40%)		Mkt cap ! $740.7M

Open	High	Low	Value	Volume
$1.27	$1.29	$1.27	$406.0K	319.3K

Buyers (Bids)

No.	Vol.	Price($)
1	13987	$1.27

Sellers (Offers)

Price($)	Vol.	No.
$1.29	1380	1

View Market Depth

No.	Vol.	Price($)
1	13987	1.265
2	16380	1.260
3	14380	1.255
3	103380	1.250
1	4000	1.225

Price($)	Vol.	No.
1.285	1380	1
1.290	27010	3
1.295	25880	2
1.300	59168	4
1.325	9001	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

PYC (ASX) Chart

Hope so Heks but they have always had high hopes, expectations...

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hope so Heks but they have always had high hopes, expectations...

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News